OR8J3 Antibody

What is OR8J3 and what biological systems is the antibody used to study?

OR8J3 (Olfactory Receptor, Family 8, Subfamily J, Member 3) is a member of the olfactory receptor protein family involved in sensory perception. This protein belongs to the G-protein coupled receptor (GPCR) superfamily and is primarily expressed in olfactory sensory neurons. OR8J3 antibodies are used to study olfactory signal transduction pathways, neuronal development, and potential ectopic expression of this receptor in non-olfactory tissues.

The antibodies against OR8J3 are specifically designed to detect endogenous levels of total OR8J3 protein, particularly targeting the C-terminal region of the protein . They are primarily used in human tissue and cell samples, with validated reactivity to human OR8J3. Common alternative names for this target include Olfactory receptor 8J3 and Olfactory receptor OR11-173 .

What applications are OR8J3 antibodies validated for?

OR8J3 antibodies have been validated for multiple laboratory applications, with the most common being:

• Western Blotting (WB): For detecting OR8J3 protein in cell or tissue lysates

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of OR8J3

• Immunofluorescence (IF): For visualizing OR8J3 localization in fixed cells

• Immunocytochemistry (ICC): For examining OR8J3 expression in cultured cells

Most commercially available OR8J3 antibodies are compatible with human samples, and researchers should verify cross-reactivity with other species before use in comparative studies . Current publications indicate limited cross-reactivity with non-human samples.

What are the key differences between available OR8J3 antibody formats?

OR8J3 antibodies are available in various formats to suit different experimental needs:

• Conjugation status:

  • Unconjugated primary antibodies are the most common form and provide flexibility for downstream detection methods

  • Conjugated versions with fluorescent labels (FITC), enzymes (HRP), or affinity tags (Biotin) are available for direct detection

  • APC-conjugated antibodies for flow cytometry applications

• Host species and clonality:

  • Most OR8J3 antibodies are rabbit polyclonal antibodies

  • Polyclonal antibodies recognize multiple epitopes on the OR8J3 protein, potentially increasing sensitivity but with batch-to-batch variation

• Target region specificity:

  • C-terminal targeting antibodies (most common), recognizing amino acids 244-272

  • Other variants targeting specific regions, such as amino acids 222-271

The choice between these formats depends on the specific requirements of your experimental setup, including detection method, sample type, and potential for cross-reactivity with other proteins.

What are the optimal conditions for using OR8J3 antibody in Western blotting?

For optimal Western blot results with OR8J3 antibody, follow these evidence-based methodological guidelines:

• Sample preparation:

  • Use RIPA or NP-40 based lysis buffers with protease inhibitors

  • Prepare 20-40 μg of total protein per lane from human cell lines or tissue samples

  • Ensure complete denaturation by heating samples at 95°C for 5 minutes in reducing sample buffer

• Gel electrophoresis and transfer:

  • 10-12% SDS-PAGE gels are recommended for optimal resolution

  • Transfer to PVDF membranes (preferred over nitrocellulose for this antibody)

  • Verify transfer efficiency with reversible protein staining

• Antibody incubation:

  • Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

  • Primary antibody dilution: 1:500 to 1:2000 in blocking solution

  • Incubation: Overnight at 4°C with gentle agitation

  • Secondary antibody: Anti-rabbit IgG conjugated with HRP at 1:5000 to 1:10,000 dilution

• Detection:

  • Enhanced chemiluminescence (ECL) with exposure times ranging from 30 seconds to 5 minutes

  • Expected molecular weight of OR8J3: approximately 35-40 kDa

Troubleshooting notes: If background is high, increase blocking time and washing steps. If signal is weak, try longer primary antibody incubation or signal amplification methods.

How can OR8J3 antibody be optimized for immunofluorescence applications?

Successful immunofluorescence with OR8J3 antibody requires careful optimization of fixation, permeabilization, and detection protocols:

• Cell preparation and fixation:

  • Cultured cells: Grow on glass coverslips to 70-80% confluence

  • Fixation options (comparative effectiveness):

    • 4% paraformaldehyde (15 minutes, room temperature) - Preferred method

    • Methanol (-20°C, 10 minutes) - Alternative when paraformaldehyde gives high background

    • Acetone/methanol (1:1, -20°C, 10 minutes) - For difficult epitopes

• Permeabilization and blocking:

  • Permeabilize with 0.1-0.3% Triton X-100 in PBS for 10 minutes

  • Block with 5-10% normal serum (from same species as secondary antibody) with 1% BSA in PBS for 1 hour

• Antibody incubation:

  • Primary antibody dilution: 1:50 to 1:200 in blocking buffer

  • Incubation time: 2 hours at room temperature or overnight at 4°C

  • Secondary antibody: Anti-rabbit IgG conjugated with fluorophore at 1:200 to 1:500

  • Include DAPI (1 μg/ml) for nuclear counterstaining

• Mounting and imaging:

  • Mount with anti-fade medium containing DAPI

  • Confocal microscopy with appropriate filter sets for the secondary antibody fluorophore

  • Expected pattern: Primarily membrane localization with potential cytoplasmic signal

For dual staining experiments, ensure secondary antibodies have non-overlapping emission spectra and are raised in different host species to prevent cross-reactivity .

What conjugation options are available for OR8J3 antibody and how should they be selected?

OR8J3 antibodies can be custom conjugated with various labels to suit specific experimental needs. Selection should be based on the detection system, sensitivity requirements, and potential for spectral overlap in multiplexed experiments.

Available conjugation options include:

Selection considerations:

• Detection system compatibility: Ensure your instruments have appropriate excitation sources and filters

• Brightness requirements: Match fluorophore brightness to target abundance (brighter dyes for low-abundance targets)

• Spectral separation: Choose conjugates with minimal spectral overlap for multiplexed experiments

• Sample autofluorescence: Select dyes with emission spectra distinct from natural sample autofluorescence

• Photostability needs: Consider photobleaching resistance for time-lapse or repeated imaging

How can OR8J3 antibody be incorporated into high-throughput antibody screening workflows?

Integrating OR8J3 antibody into high-throughput screening requires adaptation of traditional methods to automated platforms. Based on recent methodological advances, researchers can implement the following approach:

• Genotype-phenotype linked screening system:

  • Utilize dual-expression vector systems that express both immunoglobulin heavy and light chains

  • Express membrane-bound antibodies on cell surfaces (e.g., FreeStyle 293 cells) for rapid phenotypic screening

  • Normalize expression using fluorescent reporters like Venus fused to the cytoplasmic domain

  • Screen using flow cytometry for antigen binding

• Bulk screening optimization:

  • Mix transformants after transfection for simultaneous testing against multiple probes

  • Use fluorescently-labeled antigens with distinct fluorophores (e.g., Alexa647 and Alexa568) to identify differential binding

  • Sort positive populations using FACS for further analysis

• NGS integration:

  • Sequence CDR3 regions from sorted populations to identify unique clones

  • Link antigen-binding features to genetic information for comprehensive analysis

  • Use unique identifiers such as heavy chain CDR3 sequences for clone identification

This high-throughput approach significantly reduces the labor-intensive steps of traditional antibody screening, which typically involves independent cloning of heavy and light chains, co-expression, and purification of individual recombinant antibodies. The success rate for paired Ig fragment cloning can reach approximately 75.9% using optimized protocols .

What are the critical validation steps for confirming OR8J3 antibody specificity?

Rigorous validation is essential to ensure experimental reproducibility and reliable data interpretation with OR8J3 antibodies. Implement these critical validation steps:

• Positive and negative control samples:

  • Positive controls: Human tissues/cells with known OR8J3 expression (olfactory epithelium)

  • Negative controls: Tissues/cells without OR8J3 expression or OR8J3 knockout models

  • Overexpression systems: HEK293 cells transfected with OR8J3 expression constructs

• Epitope-specific validation:

  • Peptide competition assay: Pre-incubation with immunizing peptide should abolish specific signal

  • For C-terminal targeting antibodies (aa 244-272), verify with peptide corresponding to this region

• Orthogonal detection methods:

  • Correlate protein detection with mRNA expression (RT-PCR, RNA-seq)

  • Compare results from antibodies targeting different epitopes

  • Use multiple detection methods (WB, IF, ELISA) with the same antibody

• Specificity tests:

  • siRNA/shRNA knockdown of OR8J3 should reduce signal

  • Cross-reactivity tests with closely related olfactory receptors

  • Immunoprecipitation followed by mass spectrometry to confirm target identity

• Lot-to-lot consistency evaluation:

  • Compare new antibody lots with previously validated lots

  • Maintain detailed records of optimal working conditions for each lot

Implementing these validation steps is particularly important for olfactory receptors like OR8J3, which belong to a large family with high sequence similarity that can lead to cross-reactivity issues.

How can OR8J3 antibody be used in multiplex imaging systems?

Multiplex imaging with OR8J3 antibody allows simultaneous detection of multiple targets to study co-localization, protein interactions, and cellular context. Advanced methodological approaches include:

• Multi-color immunofluorescence:

  • Use OR8J3 antibody conjugated with spectrally distinct fluorophores

  • Choose fluorophores with minimal spectral overlap (e.g., AF488 and AF647)

  • Apply sequential staining protocols when using antibodies from the same host species:

    • First antibody: Apply at lower concentration, detect with Fab fragment secondaries

    • Block with excess irrelevant IgG from same species

    • Second antibody: Apply and detect with full secondary antibody

• Cyclic immunofluorescence (CycIF):

  • Perform iterative rounds of OR8J3 antibody staining, imaging, and signal removal

  • Chemical inactivation methods: Use 0.5-1.5% H₂O₂ in acidic buffer to quench fluorophores

  • Antibody stripping: Glycine-SDS buffer (pH 2.5) or 6M urea/2M SDS solution

  • Re-probe membrane with antibodies against other targets of interest

• Mass cytometry integration:

  • Conjugate OR8J3 antibody with rare earth metals

  • Combine with other metal-labeled antibodies for highly multiplexed analysis

  • Analyze using CyTOF (cytometry time-of-flight) for 40+ parameters simultaneously

• Spatial transcriptomics correlation:

  • Combine OR8J3 antibody staining with in situ RNA detection methods

  • Correlate protein localization with mRNA expression patterns

  • Use computational methods to integrate protein and RNA spatial data

When designing multiplex experiments, carefully consider antibody compatibility, potential cross-reactivity, epitope masking effects, and appropriate controls to validate multiplexed signals .

What are common causes of non-specific binding with OR8J3 antibody and how can they be mitigated?

Non-specific binding is a frequent challenge when working with OR8J3 antibodies. The following table outlines common causes and evidence-based solutions:

For OR8J3 specifically, due to its nature as an olfactory receptor with multiple family members, consider adding a pre-adsorption step with peptides from closely related olfactory receptors to reduce cross-reactivity issues .

How can OR8J3 antibody signal be enhanced for detecting low-abundance targets?

When studying OR8J3 in tissues or cells with low expression levels, signal enhancement techniques are crucial for reliable detection:

• Signal amplification methods:

  • Tyramide signal amplification (TSA): Can increase sensitivity 10-100 fold

    • Apply HRP-conjugated secondary antibody

    • Add fluorophore-conjugated tyramide

    • HRP converts tyramide to reactive intermediate that binds nearby proteins

  • Poly-HRP systems: Use secondary antibodies with multiple HRP molecules attached

  • Biotin-streptavidin amplification: Multiple step protocol with biotinylated secondary and streptavidin-conjugated reporter

• Sample preparation optimization:

  • Antigen retrieval: Heat-induced (citrate buffer, pH 6.0, 95°C for 20 minutes) or enzymatic (proteinase K)

  • Concentration of target protein: Immunoprecipitation before Western blotting

  • Subcellular fractionation: Enrich membrane fractions for OR8J3 detection

• Detection system enhancements:

  • Super-resolution microscopy (STED, STORM) for improved spatial resolution

  • Highly sensitive ECL substrates for Western blotting (femtogram detection limit)

  • Cooled CCD cameras with extended exposure times for weak fluorescent signals

• Antibody cocktail approach:

  • Use multiple OR8J3 antibodies targeting different epitopes simultaneously

  • Combine antibodies that detect different post-translational modifications

  • Apply a mixture of monoclonal and polyclonal antibodies for comprehensive epitope coverage

Each enhancement method should be validated with appropriate controls to ensure that increased signal represents specific target detection rather than amplified background .

What strategies can overcome epitope masking when using OR8J3 antibody?

Epitope masking can significantly impact OR8J3 antibody binding, particularly for C-terminal targeting antibodies. Implement these methodological approaches to maximize epitope accessibility:

• Antigen retrieval optimization:

  • Comparative effectiveness of retrieval methods for OR8J3:

    • Heat-induced epitope retrieval (HIER): Most effective using Tris-EDTA buffer (pH 9.0)

    • Pressure cooker method: 125°C for 30-60 seconds in citrate buffer (pH 6.0)

    • Microwave heating: 5 minutes at full power, 15 minutes at 30% power

  • Progressive retrieval: Start with mild methods, increase intensity until optimal signal-to-noise ratio is achieved

• Protein denaturation strategies:

  • SDS treatment (0.5-2%) followed by thorough washing

  • Guanidine HCl (6M) incubation for 10 minutes

  • Urea (8M) treatment for exposing buried epitopes

• Proteolytic treatment:

  • Enzyme panel testing (comparative effectiveness):

    • Proteinase K: 10-20 μg/ml, 5-15 minutes at 37°C

    • Trypsin: 0.1%, 10-30 minutes at 37°C

    • Pepsin: 0.5%, 5-15 minutes at 37°C

  • Sequential application of heat and enzymatic retrieval for synergistic effect

• Sample preparation modifications:

  • For fixed tissues: Reduce fixation time (<24 hours in 10% neutral buffered formalin)

  • For frozen sections: Use acetone fixation instead of paraformaldehyde

  • For cells: Mild permeabilization with digitonin (50 μg/ml) instead of Triton X-100

• Alternative antibody approaches:

  • Switch to antibodies targeting different epitopes (e.g., from C-terminal to N-terminal)

  • Use antibodies with different species origins

  • Try both polyclonal and monoclonal antibodies for the same target

These approaches should be systematically tested and optimized for specific applications, as the effectiveness of each method varies depending on sample type, fixation method, and the specific OR8J3 epitope being targeted .

How can OR8J3 antibody be utilized in single-cell analysis techniques?

Single-cell analysis with OR8J3 antibody enables investigation of cellular heterogeneity in protein expression, localization, and modifications. Advanced methodological approaches include:

• Single-cell Western blotting:

  • Capture individual cells in microwells on a polyacrylamide gel

  • Lyse cells in situ and separate proteins by size using microfluidic electrophoresis

  • Immobilize proteins and probe with OR8J3 antibody

  • Detect with fluorescent secondary antibodies and quantify signal intensity

• Mass cytometry (CyTOF):

  • Label OR8J3 antibody with rare earth metals

  • Combine with other metal-labeled antibodies for multiparameter analysis

  • Analyze cells individually using time-of-flight mass spectrometry

  • Create high-dimensional data visualization using tSNE or UMAP algorithms

• Integration with single-cell transcriptomics:

  • CITE-seq approach: Tag OR8J3 antibody with oligonucleotide barcodes

  • Capture both protein information (via antibody tags) and mRNA (via oligo-dT)

  • Sequence to obtain simultaneous protein and gene expression profiles

  • Correlate OR8J3 protein levels with mRNA expression at single-cell resolution

• Microfluidic approaches:

  • Droplet-based single-cell isolation

  • On-chip immunostaining with OR8J3 antibody

  • Combine with live-cell imaging for temporal dynamics

  • Automated image analysis for quantitative measurements

These techniques allow researchers to examine OR8J3 expression patterns in heterogeneous cell populations, potentially revealing subpopulations with distinct functional characteristics that would be masked in bulk analyses .

What are the considerations for using OR8J3 antibody in protein-protein interaction studies?

Investigating OR8J3 protein interactions requires careful methodological considerations to maintain native interaction states while enabling specific detection:

• Co-immunoprecipitation optimization:

  • Lysis buffer selection:

    • Digitonin-based (1%) for membrane protein complexes

    • CHAPS-based (1%) for preserving transmembrane protein interactions

    • Avoid harsh detergents like SDS that disrupt protein-protein interactions

  • Cross-linking options:

    • DSP (dithiobis(succinimidyl propionate)) - cleavable, membrane permeable

    • Formaldehyde (0.5-1%) - short spacer arm, reversible

    • DTBP (dimethyl 3,3'-dithiobispropionimidate) - cleavable, amine-reactive

• Proximity ligation assay (PLA):

  • Apply OR8J3 antibody with antibody against potential interacting partner

  • Use species-specific secondary antibodies with attached DNA oligonucleotides

  • Oligonucleotides hybridize when proteins are in close proximity (<40 nm)

  • Rolling circle amplification produces fluorescent signal at interaction sites

  • Quantify discrete fluorescent spots indicating specific interactions

• FRET-based approaches:

  • Directly label OR8J3 antibody with donor fluorophore

  • Label interaction partner antibody with acceptor fluorophore

  • Measure energy transfer efficiency as indicator of proximity

  • Calculate FRET efficiency using acceptor photobleaching or spectral unmixing

• Split reporter protein complementation:

  • Express OR8J3 fused to one fragment of a reporter protein

  • Express potential interaction partner fused to complementary fragment

  • Reporter activity indicates protein-protein interaction

  • Compatible with live-cell imaging for dynamic interaction studies

When designing these experiments, consider the membrane-bound nature of OR8J3 as an olfactory receptor, which may require specialized approaches to maintain native conformation and interaction capability .

How does sample preparation affect OR8J3 antibody specificity and sensitivity?

Sample preparation plays a critical role in determining the success of OR8J3 antibody-based experiments. Different preparation methods have distinct impacts on antibody performance:

• Fixation methods - comparative analysis:

• Tissue processing factors:

  • Fresh vs. frozen vs. FFPE samples:

    • Fresh: Highest epitope preservation but limited stability

    • Frozen: Good epitope preservation with minimal fixation artifacts

    • FFPE: Requires robust antigen retrieval for C-terminal epitopes

  • Section thickness:

    • 5-8 μm optimal for immunohistochemistry

    • 10-20 μm for confocal z-stack imaging

    • 40-100 μm for tissue clearing and 3D reconstruction

• Cell preparation variables:

  • Adherent vs. suspension cultures:

    • Adherent: Direct fixation on growth surface preferred

    • Suspension: Gentle centrifugation (300g) before fixation

  • Growth conditions:

    • Confluence affects membrane protein expression

    • Serum starvation may alter OR8J3 expression patterns

    • Cell stress can induce translocation of membrane proteins

• Buffer composition effects:

  • pH sensitivity: Optimal range 7.2-7.4 for antibody binding

  • Ionic strength: 150 mM NaCl optimal; higher concentrations may reduce non-specific binding

  • Detergent effects:

    • Triton X-100: Effective for full permeabilization

    • Saponin: Gentler, reversible permeabilization

    • Digitonin: Selective permeabilization of plasma membrane

Understanding these variables allows researchers to optimize detection of OR8J3 while maintaining sample integrity and experimental reproducibility .

What are the current limitations of OR8J3 antibodies and future directions for improvement?

Current research with OR8J3 antibodies faces several methodological challenges that ongoing technological developments aim to address:

• Current limitations:

  • Specificity concerns due to sequence homology with other olfactory receptors

  • Limited validation across diverse experimental conditions and systems

  • Predominantly polyclonal antibodies with potential batch-to-batch variation

  • Restricted species reactivity, primarily limited to human samples

  • Limited structural information about binding epitopes

• Technological advancements addressing these limitations:

  • Development of monoclonal antibodies with defined epitope recognition

  • Recombinant antibody production for consistent batch quality

  • Expanded validation using knockout/knockdown controls and orthogonal methods

  • Structure-guided epitope selection to improve specificity

  • Cross-species conserved epitope targeting for comparative studies

• Emerging methodologies for future applications:

  • Single-domain antibodies (nanobodies) for improved access to sterically hindered epitopes

  • Switchable antibodies with controllable binding properties

  • Genetically encoded intrabodies for live-cell tracking of OR8J3

  • Machine learning approaches for optimal epitope prediction and antibody design

• Integration with other technologies:

  • Combination with CRISPR-based tagging for endogenous protein tracking

  • Integration with super-resolution microscopy for nanoscale localization

  • Antibody-guided proteomics for comprehensive interaction networks

As these technological improvements progress, researchers can anticipate more specific, sensitive, and versatile OR8J3 antibody tools that will enable deeper insights into olfactory receptor biology and potential non-canonical functions in other tissues .

How should researchers interpret and report OR8J3 antibody-based results?

To ensure reproducibility and reliability in OR8J3 antibody-based research, investigators should follow these evidence-based reporting practices:

• Essential antibody information:

  • Complete antibody identification (catalog number, clone ID, lot number)

  • Host species, clonality, and isotype

  • Target epitope details (e.g., "C-terminal region, amino acids 244-272")

  • Validation methods performed and results obtained

• Detailed methodology reporting:

  • Sample preparation specifics:

    • Fixation method, duration, and temperature

    • Buffer compositions with exact pH values

    • Antigen retrieval protocols with precise conditions

  • Antibody usage parameters:

    • Dilution ratios with diluent composition

    • Incubation times, temperatures, and conditions

    • Washing procedures (number, duration, buffer composition)

  • Detection system specifications:

    • Secondary antibody details (host, target, conjugate)

    • Signal amplification methods if used

    • Image acquisition settings for microscopy

• Controls documentation:

  • Positive controls: Specify tissues/cells with known OR8J3 expression

  • Negative controls: Document OR8J3-negative samples or knockout validation

  • Technical controls: Secondary-only, isotype controls, peptide competition

• Quantification methods:

  • Image analysis software and version

  • Quantification parameters (intensity thresholds, region selection criteria)

  • Statistical methods for data comparison

  • Replicate information (technical vs. biological, number of repeats)